Table 1.
No | Age/sex | Cholelithiasis | Macroscopic type | Microscopic type | Immunostains | s/u HCG | Ref. No |
---|---|---|---|---|---|---|---|
1 | 63/F | + | Non-specific | AC + Choriocarcinoma | HCG (-) | ND | 1 |
2 | 29/F | + | Protruded | AC + Choriocarcinoma | HCG (+), AFP (-), CEA (-) | Elevated | 2 |
3 | 48/F | - | Protruded | AC + Choriocarcinoma | HCG (+) | Elevated | 3 |
4 | 83/F | - | Protruded | ASC | HCG (+), AFP(-), CEA (+) | Elevated | 4 |
5 | 68/F | - | Infiltrating | UC, pleomorphic type | HCG (+), VIM (+), CEA (+) | ND | 5 |
6 | 65/F | + | Protruded | UC, pleomorphic type | HCG (+), Som (+), CEA (+) | ND | 5 |
7 | 68/F | + | Protruded | UC, pleomorphic type | HCG (+), PP (+), Som (+), Gas (+), CEA (+) | ND | 5 |
8 | 68/F | - | Infiltrating | UC, pleomorphic type | HCG (+), Gas (+), CEA (+) | ND | 5 |
9 | 69/M | - | Protruded | UC, spindle cell or ps | HCG (+), Vim (+), Gas (+), CEA (+) | ND | 5 |
10 | 61/M | - | Protruded | UC, spindle cell or ps | HCG (+), Vim (+), Som (+), Gas (+), CEA (+) | ND | 5 |
11 | 66/M | - | Protruded | UC, spindle cell or ps | HCG (+), Vim (+), PP (+), CEA (+) | ND | 5 |
12 | 61/F | + | Protruded | UC, spindle cell or ps | HCG (+), Vim (+), PP (+), Ser(+), Som (+), Gas (+), CEA (+) | ND | 5 |
13 | 62/F | + | Infiltrating | UC, spindle cell or ps | HCG (+), Vim(+), Ser(+), Som(+), Gas (+), CEA (+) | ND | 5 |
14 | 41/F | ND | ND | ETT | HCG (+), PlAP (+) | Elevated | 6 |
15 | 79/M | - | Protruded | AC | HCG (+), PlAP (+) | NM | * |
s/u:serum and/or urinary; HCG:human chorionic gonadotropin; AC:adenocarcinoma; ND:not described; AFP:alfa-fetoprotein; CEA:carcinoembryonic antigen; ASC:adenosquamous cell carcinoma; UC:undifferentiated carcinoma; Vim:vimentin; Som:somatostatin; PP:pancreatic polypeptide; Gas:gastrin; ps:pseudosarcomatous; Ser:serotonin; ETT: extrauterine trophoblastic tumor; PlAP:placental alkaline phosphatase; NM:not measured; *:our case.